Screening for Dispensing Risk During High-Volume Pharmacy Periods

Abstract

High-volume pharmacy periods, such as during influenza seasons or public health emergencies, present increased risks for dispensing errors, threatening patient safety and healthcare outcomes. This review critically examines the mechanisms contributing to dispensing risk during these periods, explores the epidemiology and burden of medication errors, delineates risk factors and clinical features, and assesses current diagnostic, management, and mitigation strategies. Recent advances in workflow optimization, digital screening tools, and guideline-based interventions are discussed, providing practical insights for clinicians and pharmacists seeking to minimize risk and enhance medication safety in high-pressure pharmacy settings. The article synthesizes recent evidence and expert recommendations to propose a framework for systematic risk screening, with implications for policy, practice, and future research.

Introduction

Pharmacies serve as critical access points for medication delivery, especially during periods of heightened demand such as flu outbreaks, pandemics, or end-of-year insurance changes. During these high-volume periods, the risk of dispensing errors rises significantly, posing a substantial threat to patient safety. Dispensing errors not only compromise therapeutic efficacy but may also result in adverse drug events, hospitalizations, and increased healthcare costs. The necessity for rapid and accurate screening tools and processes to identify and mitigate dispensing risk is therefore paramount. This article aims to provide a comprehensive overview of the current landscape and challenges in screening for dispensing risk in high-volume pharmacy settings, underscored by recent scientific evidence and clinical guidelines.

Epidemiology / Disease Burden

Medication errors, including incorrect dispensing, represent a leading category of preventable harm in healthcare. Studies estimate that community pharmacies experience a dispensing error rate ranging from 0.04% to over 1% of prescriptions, with higher rates observed during peak periods. The global burden is significant; in the United States alone, dispensing errors contribute to thousands of adverse events annually, with an associated economic impact exceeding billions of dollars. High-volume periods amplify this burden, with error rates reportedly increasing by up to 50% during such times, according to recent observational studies. The disease burden is not limited to direct harm but extends to decreased patient trust, workflow disruption, and reputational risk for healthcare providers.

Pathophysiology

The pathophysiology of dispensing risk in high-volume periods is multifactorial. Cognitive overload, task interruption, and time pressure are principal contributors. Pharmacists must simultaneously process multiple prescriptions, verify insurance, counsel patients, and manage inventory, all under stringent time constraints. This cognitive burden impairs attention, working memory, and decision-making, increasing the likelihood of both omission and commission errors. Environmental factors, such as noise and inadequate staffing, further exacerbate risk by disrupting concentration and workflow continuity. Mechanistically, failures in prescription verification, look-alike/sound-alike medication confusion, and manual data entry errors are common pathways leading to dispensing mistakes.

Risk Factors

Risk factors for dispensing errors during high-volume periods are diverse. Key factors include high prescription volume, insufficient staffing, fatigue, inexperience among pharmacy personnel, complex medication regimens, and the presence of high-alert medications. System-level contributors, such as poor electronic health record (EHR) integration, lack of standardized procedures, and inadequate error reporting systems, heighten vulnerability. Patient-specific factors such as polypharmacy, language barriers, and cognitive impairment also increase the risk of errors. Importantly, the interplay between human, organizational, and technological factors determines the overall risk profile in any given pharmacy setting.

Clinical Features

Dispensing errors may manifest clinically through adverse drug events, therapeutic failure, allergic reactions, or exacerbation of underlying conditions. In the pharmacy, warning signs include frequent prescription clarifications, increased near-miss reports, delayed medication pickups, and patient complaints. Clinicians may observe unexplained changes in clinical status, unexpected laboratory results, or lack of response to therapy. Early identification of these features is critical for timely intervention and prevention of harm.

Diagnosis

Diagnosing dispensing risk involves both retrospective error detection and prospective risk screening. Retrospective methods include incident reporting systems, root cause analyses, and audit of prescription records. Prospective screening relies on checklists, risk stratification tools, and electronic algorithms that flag high-risk prescriptions or workflow anomalies. Integration of real-time risk assessment into pharmacy management systems is increasingly advocated, enabling prompt identification and mitigation of dispensing hazards before they reach the patient.

Treatment & Managemen

Effective management of dispensing risk during high-volume periods requires a multifaceted approach. Staff training on error prevention, implementation of standardized dispensing protocols, and double-check systems are foundational measures. Technology-enabled solutions such as barcoding, computerized physician order entry (CPOE), and clinical decision support reduce human error by automating verification steps. Communication strategies, including structured handoffs and regular team huddles, facilitate situational awareness and error reporting. When errors do occur, prompt disclosure, root cause analysis, and corrective feedback are essential to prevent recurrence and foster a culture of safety.

Recent Advances / Emerging Therapies

Recent years have witnessed significant advances in dispensing risk mitigation. Artificial intelligence (AI) and machine learning models are being deployed to predict and flag high-risk prescriptions based on patient, drug, and workflow variables. Digital dashboards provide real-time error tracking, enabling pharmacies to allocate resources dynamically during peak demand. Remote verification by offsite pharmacists, telepharmacy, and automated dispensing cabinets (ADCs) further augment capacity and reduce human workload. Emerging research highlights the promise of integrating these technologies with behavioral interventions, such as nudges and reminders, to optimize risk screening.

Guideline Recommendations

Professional bodies, including the Institute for Safe Medication Practices (ISMP) and the American Society of Health-System Pharmacists (ASHP), advocate for comprehensive risk assessment and mitigation strategies tailored to high-volume scenarios. Recommended practices include preemptive staffing adjustments, mandatory use of barcoding and double-checks for high-alert medications, and routine error reporting with non-punitive feedback. Integration of electronic risk screening tools is specifically encouraged during anticipated surges in prescription volume. Continuous quality improvement (CQI) programs and regular training on error prevention are also emphasized as cornerstones of safe dispensing practice.

Conclusion

Screening for dispensing risk during high-volume pharmacy periods is a critical component of patient safety and effective healthcare delivery. The interplay of human, organizational, and technological factors demands a systematic, evidence-based approach to risk mitigation. Recent advances in digital screening tools, workflow optimization, and guideline-driven protocols offer promising avenues to reduce error rates and enhance patient outcomes. Ongoing research, investment in staff training, and adoption of best practices will be essential to meet the challenges of high-volume pharmacy operations in an increasingly complex healthcare landscape.